Counting Cancer-busting Oxygen Molecules Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.Therapeutic Approach Gives Hope for Multiple Myeloma A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.Protein Protects Against Flu in Mice The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.Crowdfunding the Fight Against Cancer From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Natural Protein Points to New Inflammation Treatment Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.Tricked-Out Immune Cells Could Attack Cancer New cell-engineering technique may lead to precision immunotherapies.Therapy Halts Progression of Lou Gehrig’s Disease Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.Crouching Protein, Hidden Enzyme A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.Utilizing Antibodies from Ebola Survivors A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.Engineering Foe into Friend Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
05 Nov 2012 - 06 Nov 2012 London, UK Cell Culture & Bioprocessing Congress
05 Nov 2012 - 07 Nov 2012 Shanghai, China Biologics World China 2012
07 Nov 2012 - 08 Nov 2012 Philadelphia, PA USA Automation Fair 2012
12 Nov 2012 - 13 Nov 2012 Washington, DC, USA Cell Culture World Congress USA
12 Nov 2012 - 12 Nov 2012 Taiwan Biologics World Taiwan 2012
12 Nov 2012 - 14 Nov 2012 Johannes Gutenberg-University, Mainz, Germany Introductory GastroPlus™ Simulation & Modeling Workshop for Drug Absorption, Pharmacokinetics and Pharmacodynamics
14 Nov 2012 - 14 Nov 2012 Stevenage, Hertfordshire, UK 3rd Annual Miniaturisation Event - Micro Scale Bioprocess Development
15 Nov 2012 - 16 Nov 2012 Frankfurt, Germany 8th Annual Project & Portfolio Management in Pharmaceutical Industry
23 Nov 2012 - 23 Nov 2012 Islington, London, Introduction to Photostability